Mad 3 Activators
The chemical class termed Mad 3 Activators includes compounds that can potentially modulate the activity or expression of the MXD3 protein through indirect mechanisms. These chemicals target various signaling pathways and cellular processes, creating an environment that can influence MXD3. In the first paragraph, the focus is on compounds like Retinoic Acid, Lithium Chloride, PD98059, LY294002, Rapamycin, and SB431542. These chemicals influence pathways such as retinoic acid signaling, Wnt signaling through GSK-3β inhibition, the MAPK/ERK pathway, PI3K/AKT signaling, mTOR signaling, and TGF-β signaling, respectively. While none of these pathways directly involve MXD3, their modulation creates a cellular context that can affect MXD3's expression or activity. For example, retinoic acid's role in gene expression modulation, lithium chloride's effect on Wnt signaling, and PD98059's impact on the MAPK/ERK pathway each alter the cellular landscape, potentially influencing MXD3.
In the second paragraph, attention shifts to Trichostatin A, Y-27632, BAY 11-7082, SP600125, Forskolin, and Wortmannin. These compounds impact the epigenetic landscape, cellular architecture, NF-κB signaling, JNK signaling, cAMP levels, and PI3K/AKT signaling, respectively. Their actions, ranging from altering gene expression through epigenetic modifications to affecting cell shape, motility, stress responses, and cellular signaling dynamics, can create a milieu conducive to changes in MXD3 activity or expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of Vitamin A, modulates gene expression through retinoic acid receptors. This can influence the differentiation pathways in which MXD3 is involved, potentially upregulating its expression in certain cell types. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, a kinase involved in the Wnt signaling pathway. While directly not affecting MXD3, inhibition of GSK-3β can alter cellular dynamics in pathways where MXD3 is potentially a downstream effector. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, part of the MAPK/ERK pathway. By influencing this pathway, it could indirectly affect the cellular context in which MXD3 operates, possibly altering its activity or expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, impacting the AKT pathway. Since PI3K/AKT signaling is integral to many cellular processes, its modulation can indirectly influence the activity or expression of MXD3 by altering cellular signaling dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator in cell growth and metabolism. This inhibition could indirectly affect MXD3's function or expression through changes in cellular metabolic and growth signaling. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β receptor. Although MXD3 is not directly involved in the TGF-β pathway, inhibiting this pathway can alter the cellular environment in a manner that potentially affects MXD3 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, affecting gene expression patterns broadly. This could indirectly influence MXD3 by altering the epigenetic landscape of the cell. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, impacting cell shape and motility. This could affect MXD3 by altering cellular architecture and signaling related to cytoskeletal dynamics. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-κB activation, potentially influencing the expression of a range of genes, possibly including those related to MXD3's function or expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP can modulate various signaling pathways that might intersect with MXD3's function, particularly in cells where MXD3 is expressed. | ||||||